Company intelligence / Profile preview

Redouble AI

New York City, New York, United Statesredouble.ai ↗

Ownership: Private
Development stage: Other

Overview

Redouble AI develops and deploys tailored, production-grade artificial intelligence solutions with integrated human-in-the-loop validation for regulated industries such as healthcare, legal, insurance, and finance. Their technology focuses on ensuring safety, reliability, scalability, and compliance by enabling real-time output validation of large language models (LLMs) using expert human feedback. The team has deep expertise in both life sciences/drug discovery automation and advanced data engineering.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Redouble AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redouble AI.

Explore the full profile